179 related articles for article (PubMed ID: 24111178)
21. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
22. A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma.
Jimenez-Macias JL; Lee YC; Miller E; Finkelberg T; Zdioruk M; Berger G; Farquhar CE; Nowicki MO; Cho CF; Fedeles BI; Loas A; Pentelute BL; Lawler SE
J Control Release; 2022 Dec; 352():623-636. PubMed ID: 36349615
[TBL] [Abstract][Full Text] [Related]
23. Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma.
Kim SS; Rait A; Kim E; DeMarco J; Pirollo KF; Chang EH
Cancer Lett; 2015 Dec; 369(1):250-8. PubMed ID: 26325605
[TBL] [Abstract][Full Text] [Related]
24. Encapsulated
Lin YL; Huang XF; Chang KF; Liao KW; Tsai NM
Int J Nanomedicine; 2020; 15():749-760. PubMed ID: 32099363
[TBL] [Abstract][Full Text] [Related]
25. Concomitant treatment of F98 glioma cells with new liposomal platinum compounds and ionizing radiation.
Charest G; Paquette B; Fortin D; Mathieu D; Sanche L
J Neurooncol; 2010 Apr; 97(2):187-93. PubMed ID: 19760366
[TBL] [Abstract][Full Text] [Related]
26. Recent Advances in the Use of Lipid-Based Nanoparticles Against Glioblastoma Multiforme.
Ortega-Berlanga B; Gonzalez C; Navarro-Tovar G
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):8. PubMed ID: 33772646
[TBL] [Abstract][Full Text] [Related]
27. Co-delivery of doxorubicin and erlotinib through liposomal nanoparticles for glioblastoma tumor regression using an in vitro brain tumor model.
Lakkadwala S; Singh J
Colloids Surf B Biointerfaces; 2019 Jan; 173():27-35. PubMed ID: 30261346
[TBL] [Abstract][Full Text] [Related]
28. Design of multifunctional peptide collaborated and docetaxel loaded lipid nanoparticles for antiglioma therapy.
Kadari A; Pooja D; Gora RH; Gudem S; Kolapalli VRM; Kulhari H; Sistla R
Eur J Pharm Biopharm; 2018 Nov; 132():168-179. PubMed ID: 30244167
[TBL] [Abstract][Full Text] [Related]
29. Local chemotherapy with cisplatin-depot for glioblastoma multiforme.
Sheleg SV; Korotkevich EA; Zhavrid EA; Muravskaya GV; Smeyanovich AF; Shanko YG; Yurkshtovich TL; Bychkovsky PB; Belyaev SA
J Neurooncol; 2002 Oct; 60(1):53-9. PubMed ID: 12416546
[TBL] [Abstract][Full Text] [Related]
30. Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma.
Treat LH; McDannold N; Zhang Y; Vykhodtseva N; Hynynen K
Ultrasound Med Biol; 2012 Oct; 38(10):1716-25. PubMed ID: 22818878
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy sensitization of glioblastoma by focused ultrasound-mediated delivery of therapeutic liposomes.
Papachristodoulou A; Signorell RD; Werner B; Brambilla D; Luciani P; Cavusoglu M; Grandjean J; Silginer M; Rudin M; Martin E; Weller M; Roth P; Leroux JC
J Control Release; 2019 Feb; 295():130-139. PubMed ID: 30537486
[TBL] [Abstract][Full Text] [Related]
32. Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain.
Charest G; Sanche L; Fortin D; Mathieu D; Paquette B
J Neurooncol; 2013 Dec; 115(3):365-73. PubMed ID: 24026531
[TBL] [Abstract][Full Text] [Related]
33. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
Shi D; Mi G; Shen Y; Webster TJ
Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
[TBL] [Abstract][Full Text] [Related]
34. Refining the delivery and therapeutic efficacy of cetuximab using focused ultrasound in a mouse model of glioblastoma: An
Porret E; Kereselidze D; Dauba A; Schweitzer-Chaput A; Jegot B; Selingue E; Tournier N; Larrat B; Novell A; Truillet C
Eur J Pharm Biopharm; 2023 Jan; 182():141-151. PubMed ID: 36529256
[TBL] [Abstract][Full Text] [Related]
35. Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.
Dréan A; Goldwirt L; Verreault M; Canney M; Schmitt C; Guehennec J; Delattre JY; Carpentier A; Idbaih A
Expert Rev Neurother; 2016 Nov; 16(11):1285-1300. PubMed ID: 27310463
[TBL] [Abstract][Full Text] [Related]
36. A review of potential applications of MR-guided focused ultrasound for targeting brain tumor therapy.
Lamsam L; Johnson E; Connolly ID; Wintermark M; Hayden Gephart M
Neurosurg Focus; 2018 Feb; 44(2):E10. PubMed ID: 29385922
[TBL] [Abstract][Full Text] [Related]
37. TRAIL and doxorubicin combination enhances anti-glioblastoma effect based on passive tumor targeting of liposomes.
Guo L; Fan L; Pang Z; Ren J; Ren Y; Li J; Chen J; Wen Z; Jiang X
J Control Release; 2011 Aug; 154(1):93-102. PubMed ID: 21609741
[TBL] [Abstract][Full Text] [Related]
38. A state-of-the-art liposome technology for glioblastoma treatment.
Hasan I; Roy S; Ehexige E; Wu R; Chen Y; Gao Z; Guo B; Chang C
Nanoscale; 2023 Nov; 15(45):18108-18138. PubMed ID: 37937394
[TBL] [Abstract][Full Text] [Related]
39. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment.
Wang D; Wang C; Wang L; Chen Y
Drug Deliv; 2019 Dec; 26(1):551-565. PubMed ID: 31928355
[TBL] [Abstract][Full Text] [Related]
40. Brainstem blood brain barrier disruption using focused ultrasound: A demonstration of feasibility and enhanced doxorubicin delivery.
Alli S; Figueiredo CA; Golbourn B; Sabha N; Wu MY; Bondoc A; Luck A; Coluccia D; Maslink C; Smith C; Wurdak H; Hynynen K; O'Reilly M; Rutka JT
J Control Release; 2018 Jul; 281():29-41. PubMed ID: 29753957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
